The invention relates to s-substituted N-1-[(hetero)aryl]alkyl-N-1-[(hetero)aryl]alkylysothio-carbamides and the physiologically active salts and bases thereof, embodied in the form of racemic mixtures (or stereoisomer mixture) or individual optical isomers. The specific physiological activity of said compounds makes it possible to use them in the form of molecular tools. Said invention also relates to Pharmaceutical compositions, containing said compounds and to a method for preventing and curing various diseases including neurodegenerative diseases as, for example Alzheimer's disease (AD). The pharmacological effect of said compounds is based on the combined cognitive-stimulating and neuroprotective action thereof, which is produced by acting on chemo-controlled calcium channels of neurone membranes, in particular the neurones regulated by glutamate receptors of the central neural system (CNS).
本发明涉及 s-取代的 N-1-[(杂)芳基]烷基-N-1-[(杂)芳基]烷基
硫代
氨基甲酸酯及其具有生理活性的盐和碱,以外消旋混合物(或立体异构体混合物)或单个光学异构体的形式体现。上述化合物的特殊生理活性使其有可能以分子工具的形式使用。本发明还涉及含有上述化合物的药物组合物,以及预防和治疗各种疾病(包括神经退行性疾病,如阿尔茨海默病(AD))的方法。所述化合物的药理作用基于其刺激认知和保护神经的综合作用,这种作用是通过作用于神经元膜的
化学控制
钙通道产生的,特别是受中枢神经系统(CNS)谷
氨酸受体调节的神经元。